BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 36815334)

  • 1. The Testing Imperative: Why the US Ending the Human Immunodeficiency Virus (HIV) Epidemic Program Needs to Renew Efforts to Expand HIV Testing in Clinical and Community-Based Settings.
    Nosyk B; Fojo AT; Kasaie P; Enns B; Trigg L; Piske M; Hutchinson AB; DiNenno EA; Zang X; Del Rio C
    Clin Infect Dis; 2023 Jun; 76(12):2206-2208. PubMed ID: 36815334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV Testing Strategies for Health Departments to End the Epidemic in the U.S.
    Delaney KP; DiNenno EA
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S6-S15. PubMed ID: 34686292
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards ending the human immunodeficiency virus epidemic in the US: State of human immunodeficiency virus screening during physician and emergency department visits, 2009 to 2014.
    Olatosi B; Siddiqi KA; Conserve DF
    Medicine (Baltimore); 2020 Jan; 99(2):e18525. PubMed ID: 31914025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in HIV Testing Among US Adults, Aged 18-64 Years, 2011-2017.
    Patel D; Johnson CH; Krueger A; Maciak B; Belcher L; Harris N; DiNenno EA
    AIDS Behav; 2020 Feb; 24(2):532-539. PubMed ID: 31595375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New pathogen, same disparities: why COVID-19 and HIV remain prevalent in U.S. communities of colour and implications for ending the HIV epidemic.
    Millett GA
    J Int AIDS Soc; 2020 Nov; 23(11):e25639. PubMed ID: 33222424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. America's HIV Epidemic Analysis Dashboard: Protocol for a Data Resource to Support Ending the HIV Epidemic in the United States.
    Sullivan PS; Woodyatt CR; Kouzouian O; Parrish KJ; Taussig J; Conlan C; Phillips H
    JMIR Public Health Surveill; 2022 Feb; 8(2):e33522. PubMed ID: 35142639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NIH in the Ending the HIV Epidemic in the US Initiative: Research Improving Practice.
    Glenshaw MT; Gaist P; Wilson A; Cregg RC; Holtz TH; Goodenow MM
    J Acquir Immune Defic Syndr; 2022 Jul; 90(S1):S9-S16. PubMed ID: 35703750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How Can Progress Toward Ending the Human Immunodeficiency Virus Epidemic in the United States Be Monitored?
    Mitchell KM; Maheu-Giroux M; Dimitrov D; Moore M; Hughes JP; Donnell D; Beyrer C; El-Sadr WM; Cohen MS; Boily MC
    Clin Infect Dis; 2022 Aug; 75(1):163-169. PubMed ID: 34849635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV Testing Preferences and Characteristics of Those Who Have Never Tested for HIV in the United States.
    Patel SN; Emerson BP; Pitasi MA; Tripp NE; Marcus R; Delaney KP; Chavez PR
    Sex Transm Dis; 2023 Mar; 50(3):175-179. PubMed ID: 36729993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Roles for Pharmacists in the "Ending the HIV Epidemic: A Plan for America" Initiative.
    McCree DH; Byrd KK; Johnston M; Gaines M; Weidle PJ
    Public Health Rep; 2020; 135(5):547-554. PubMed ID: 32780671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ending the HIV epidemic for all, not just some: structural racism as a fundamental but overlooked social-structural determinant of the US HIV epidemic.
    Bowleg L; Malekzadeh AN; Mbaba M; Boone CA
    Curr Opin HIV AIDS; 2022 Mar; 17(2):40-45. PubMed ID: 35102051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Optimizing HIV Prevention Efforts to Achieve EHE Incidence Targets.
    Jacobson EU; Hicks KA; Carrico J; Purcell DW; Green TA; Mermin JH; Farnham PG
    J Acquir Immune Defic Syndr; 2022 Apr; 89(4):374-380. PubMed ID: 35202046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluating the sensitivity of jurisdictional heterogeneity and jurisdictional mixing in national level HIV prevention analyses: context of the U.S. ending the HIV epidemic plan.
    Tatapudi H; Gopalappa C
    BMC Med Res Methodol; 2022 Nov; 22(1):304. PubMed ID: 36435750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What do the Universal Test and Treat trials tell us about the path to HIV epidemic control?
    Havlir D; Lockman S; Ayles H; Larmarange J; Chamie G; Gaolathe T; Iwuji C; Fidler S; Kamya M; Floyd S; Moore J; Hayes R; Petersen M; Dabis F;
    J Int AIDS Soc; 2020 Feb; 23(2):e25455. PubMed ID: 32091179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Towards achieving the fast-track targets and ending the epidemic of HIV/AIDS in Ethiopia: Successes and challenges.
    Assefa Y; Gilks CF; Dean J; Tekle B; Lera M; Balcha TT; Getaneh Y; Van Damme W; Hill PS
    Int J Infect Dis; 2019 Jan; 78():57-64. PubMed ID: 30391417
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV Care Continuum and Preexposure Prophylaxis Program in Federal Bureau of Prisons, United States.
    Huang XH; Thompson E; Rodriguez T
    Emerg Infect Dis; 2024 Apr; 30(13):S75-S79. PubMed ID: 38561818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simulating the End of AIDS in New York: Using Participatory Dynamic Modeling to Improve Implementation of the Ending the Epidemic Initiative.
    Martin EG; MacDonald RH; Gordon DE; Swain CA; O'Donnell T; Helmeset J; Dwicaksono A; Tesoriero JM
    Public Health Rep; 2020; 135(1_suppl):158S-171S. PubMed ID: 32735199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV Testing Trends at Visits to Physician Offices, Community Health Centers, and Emergency Departments - United States, 2009-2017.
    Hoover KW; Huang YA; Tanner ML; Zhu W; Gathua NW; Pitasi MA; DiNenno EA; Nair S; Delaney KP
    MMWR Morb Mortal Wkly Rep; 2020 Jun; 69(25):776-780. PubMed ID: 32584800
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview of the US National HIV Strategy and Ending the HIV Epidemic Initiative.
    McGee KS
    Nurs Clin North Am; 2024 Jun; 59(2):297-308. PubMed ID: 38670696
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.